Lipids and Liver: Nuevos mecanismos, biomarcadores de diagnóstico y progresión y dianas terapéuticas de enfermedad metabólica y Cáncer - GIC 21/087
Hospital Universitario Central de Asturias
Oviedo, EspañaPublicaciones en colaboración con investigadoras/es de Hospital Universitario Central de Asturias (17)
2022
-
Effects of everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 6, pp. 335-342
2021
-
Diagnosis and treatment of hepatocellular carcinoma. Update of the consensus document of the AEEH, AEC, SEOM, SERAM, SERVEI, and SETH
Medicina Clinica, Vol. 156, Núm. 9, pp. 463.e1-463.e30
2020
-
Resultados de una encuesta sobre el soporte nutricional perioperatorio en la cirugía pancreática y biliar en España
Nutricion hospitalaria, Vol. 37, Núm. 2, pp. 238-242
2019
-
A survey of Heads of Surgery and Residents on accessibility and employment in liver transplant teams in Spain
Cirugia Espanola, Vol. 97, Núm. 10, pp. 560-567
2018
-
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study
American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522
2017
-
Human immunodeficiency virus–infected liver transplant recipients with incidental hepatocellular carcinoma: A prospective multicenter nationwide cohort study
Liver Transplantation, Vol. 23, Núm. 5, pp. 645-651
2016
-
Erratum: Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study (Journal of Hepatology (2015) 62 (92-100))
Journal of Hepatology
-
Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma
Hepatology, Vol. 63, Núm. 2, pp. 488-498
-
Liver Retransplantation in Patients with HIV-1 Infection: An International Multicenter Cohort Study
American Journal of Transplantation, Vol. 16, Núm. 2, pp. 679-687
2015
-
Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study
Journal of Hepatology, Vol. 62, Núm. 1, pp. 92-100
-
Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain
Liver Transplantation, Vol. 21, Núm. 8, pp. 1056-1065
2014
-
Estudio multicéntrico sobre adenomas hepáticos
Cirugia Espanola, Vol. 92, Núm. 2, pp. 120-125
-
IV Reunión de Consenso de la Sociedad Española de Trasplante Hepático 2012. Excepciones al Model for End-stage Liver Disease en la priorización para trasplante hepático
Gastroenterologia y Hepatologia, Vol. 37, Núm. 2, pp. 83-91
2011
2010
-
Recommendations for the management of Sorafenib in patients with hepatocellular carcinoma
Gastroenterologia y Hepatologia, Vol. 33, Núm. 10, pp. 741-752
-
Tratamiento del carcinoma hepatocelular en España. Análisis de 705 casos en 62 centros
Medicina Clinica, Vol. 134, Núm. 13, pp. 569-576
2008
-
Impact of immunosuppression without steroids on rejection and hepatitis C virus evolution after liver transplantation: Results of a prospective randomized study
Liver Transplantation, Vol. 14, Núm. 12, pp. 1752-1760